MeSH Review:
Viral Load
Oxenius,
Yerly,
Ramirez,
Phillips,
Price,
Perrin,
Paton,
Aboulhab,
Karim,
Taylor,
van Heeswijk,
Hoetelmans,
Workman,
Drake,
White,
Pillay,
Valcour,
Shikuma,
Shiramizu,
Watters,
Poff,
Selnes,
Holck,
Grove,
Sacktor,
Sulkowski,
Moore,
Mehta,
Chaisson,
Thomas,
Diomandé,
Bissagnéné,
Nkengasong,
Maurice,
Monga,
Laga,
Nolan,
Gomi,
Gandotra,
Todd,
Liu,
Chen,
Lai,
Kao,
Chang,
Wu,
Shau,
Chen,
Montaner,
Reiss,
Cooper,
Vella,
Harris,
Conway,
Wainberg,
Smith,
Robinson,
Hall,
Myers,
Lange,
Lunel,
Cresta,
Vitour,
Payan,
Dumont,
Frangeul,
Reboul,
Brault,
Piette,
Huraux,
Taliani,
Gemignani,
Ferrari,
Aceti,
Bartolozzi,
Blanc,
Capanni,
Esperti,
Forte,
Guadagnino,
Mari,
Marino,
Milani,
Pasquazzi,
Rosina,
Tacconi,
Toti,
Zignego,
Messerini,
Stroffolini,
Erb,
Battegay,
Zimmerli,
Rickenbach,
Egger,
French,
Cohen,
Gange,
Burger,
Gao,
Semba,
Meyer,
Robison,
Anastos,
Pawlotsky,
Dahari,
Neumann,
Hezode,
Germanidis,
Lonjon,
Castera,
Dhumeaux,
Casado,
Sabido,
Perez-Elías,
Antela,
Oliva,
Dronda,
Mejía,
Fortún,
- Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Sperling, R.S., Shapiro, D.E., Coombs, R.W., Todd, J.A., Herman, S.A., McSherry, G.D., O'Sullivan, M.J., Van Dyke, R.B., Jimenez, E., Rouzioux, C., Flynn, P.M., Sullivan, J.L. N. Engl. J. Med. (1996)
- Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis. Drescher, K.M., Nguyen, L.T., Taneja, V., Coenen, M.J., Leibowitz, J.L., Strauss, G., Hammerling, G.J., David, C.S., Rodriguez, M. J. Clin. Invest. (1998)
- Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients. Taliani, G., Gemignani, G., Ferrari, C., Aceti, A., Bartolozzi, D., Blanc, P.L., Capanni, M., Esperti, F., Forte, P., Guadagnino, V., Mari, T., Marino, N., Milani, S., Pasquazzi, C., Rosina, F., Tacconi, D., Toti, M., Zignego, A.L., Messerini, L., Stroffolini, T. Gastroenterology (2006)
- Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Terada, K., Katamine, S., Eguchi, K., Moriuchi, R., Kita, M., Shimada, H., Yamashita, I., Iwata, K., Tsuji, Y., Nagataki, S. Lancet (1994)
- Response of lymphoepithelial parotid cysts to antiretroviral treatment in HIV-infected adults. Craven, D.E., Duncan, R.A., Stram, J.R., O'Hara, C.J., Steger, K.A., Jhamb, K., Hirschhorn, L.R. Ann. Intern. Med. (1998)
- The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative. Diomandé, F.V., Bissagnéné, E., Nkengasong, J.N., Maurice, C., Monga, B., Laga, M., Nolan, M.L. AIDS (2003)
- Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Chang, L., Ernst, T., Leonido-Yee, M., Walot, I., Singer, E. Neurology (1999)
- Septic right superior ophthalmic vein thrombosis complicated by left sphenoid sinusitis. Gomi, H., Gandotra, S., Todd, C. Scand. J. Infect. Dis. (2005)
- Predictors of virologic success in patients completing a structured antiretroviral adherence program. DeFino, M., Clark, J., Mogyoros, D., Shuter, J. The Journal of the Association of Nurses in AIDS Care : JANAC. (2004)
- Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O., Holck, P., Grove, J., Sacktor, N. Neurology (2004)
- Rejuvenating exhausted T cells during chronic viral infection. Okazaki, T., Honjo, T. Cell (2006)
- Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. Daar, E.S., Moudgil, T., Meyer, R.D., Ho, D.D. N. Engl. J. Med. (1991)
- Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Wang, T., Town, T., Alexopoulou, L., Anderson, J.F., Fikrig, E., Flavell, R.A. Nat. Med. (2004)
- The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Michael, N.L., Louie, L.G., Rohrbaugh, A.L., Schultz, K.A., Dayhoff, D.E., Wang, C.E., Sheppard, H.W. Nat. Med. (1997)
- Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Neumann, A.U., Lam, N.P., Dahari, H., Gretch, D.R., Wiley, T.E., Layden, T.J., Perelson, A.S. Science (1998)
- Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1. Paton, N.I., Aboulhab, J., Karim, F. Lancet (2002)
- Vitamin A deficiency and genital viral burden in women infected with HIV-1. French, A.L., Cohen, M.H., Gange, S.J., Burger, H., Gao, W., Semba, R.D., Meyer, W.A., Robison, E., Anastos, K. Lancet (2002)
- Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load. Rübsamen-Waigmann, H., Huguenel, E., Paessens, A., Kleim, J.P., Wainberg, M.A., Shah, A. Lancet (1997)
- Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Mellors, J.W., Muñoz, A., Giorgi, J.V., Margolick, J.B., Tassoni, C.J., Gupta, P., Kingsley, L.A., Todd, J.A., Saah, A.J., Detels, R., Phair, J.P., Rinaldo, C.R. Ann. Intern. Med. (1997)
- Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy. Dixit, N.M., Markowitz, M., Ho, D.D., Perelson, A.S. Antivir. Ther. (Lond.) (2004)
- Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group. Staszewski, S., Loveday, C., Picazo, J.J., Dellarnonica, P., Skinhøj, P., Johnson, M.A., Danner, S.A., Harrigan, P.R., Hill, A.M., Verity, L., McDade, H. JAMA (1996)
- A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Liu, C.J., Chen, P.J., Lai, M.Y., Kao, J.H., Chang, C.F., Wu, H.L., Shau, W.Y., Chen, D.S. Gastroenterology (2003)
- Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. Castedo, M., Roumier, T., Blanco, J., Ferri, K.F., Barretina, J., Tintignac, L.A., Andreau, K., Perfettini, J.L., Amendola, A., Nardacci, R., Leduc, P., Ingber, D.E., Druillennec, S., Roques, B., Leibovitch, S.A., Vilella-Bach, M., Chen, J., Este, J.A., Modjtahedi, N., Piacentini, M., Kroemer, G. EMBO J. (2002)
- Human Herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms: necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. Secchiero, P., Flamand, L., Gibellini, D., Falcieri, E., Robuffo, I., Capitani, S., Gallo, R.C., Zauli, G. Blood (1997)
- Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Bedell, R., Heath, K.V., Hogg, R.S., Wood, E., Press, N., Yip, B., O'Shaughnessy, M.V., Montaner, J.S. Antivir. Ther. (Lond.) (2003)
- Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Xu, L., Sakalian, M., Shen, Z., Loss, G., Neuberger, J., Mason, A. Hepatology (2004)
- Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity. Azzoni, L., Papasavvas, E., Chehimi, J., Kostman, J.R., Mounzer, K., Ondercin, J., Perussia, B., Montaner, L.J. J. Immunol. (2002)
- Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men. Taylor, S., van Heeswijk, R.P., Hoetelmans, R.M., Workman, J., Drake, S.M., White, D.J., Pillay, D. AIDS (2000)
- Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients. Oxenius, A., Yerly, S., Ramirez, E., Phillips, R.E., Price, D.A., Perrin, L. AIDS (2001)
- Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. Li, S., Juarez, J., Alali, M., Dwyer, D., Collman, R., Cunningham, A., Naif, H.M. J. Virol. (1999)
- A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. Montaner, J.S., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., Wainberg, M.A., Smith, D., Robinson, P., Hall, D., Myers, M., Lange, J.M. JAMA (1998)
- Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team). Descamps, D., Flandre, P., Calvez, V., Peytavin, G., Meiffredy, V., Collin, G., Delaugerre, C., Robert-Delmas, S., Bazin, B., Aboulker, J.P., Pialoux, G., Raffi, F., Brun-Vézinet, F. JAMA (2000)
- Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial. Hammer, S.M., Vaida, F., Bennett, K.K., Holohan, M.K., Sheiner, L., Eron, J.J., Wheat, L.J., Mitsuyasu, R.T., Gulick, R.M., Valentine, F.T., Aberg, J.A., Rogers, M.D., Karol, C.N., Saah, A.J., Lewis, R.H., Bessen, L.J., Brosgart, C., DeGruttola, V., Mellors, J.W. JAMA (2002)
- Antiviral action of ribavirin in chronic hepatitis C. Pawlotsky, J.M., Dahari, H., Neumann, A.U., Hezode, C., Germanidis, G., Lonjon, I., Castera, L., Dhumeaux, D. Gastroenterology (2004)
- Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Romero-Gómez, M., Del Mar Viloria, M., Andrade, R.J., Salmerón, J., Diago, M., Fernández-Rodríguez, C.M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., Muñoz-De-Rueda, P., López-Serrano, P., Gila, A., Gutiérrez, M.L., Pérez, C., Ruiz-Extremera, A., Suárez, E., Castillo, J. Gastroenterology (2005)
- Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Alric, L., Fort, M., Izopet, J., Vinel, J.P., Charlet, J.P., Selves, J., Puel, J., Pascal, J.P., Duffaut, M., Abbal, M. Gastroenterology (1997)
- Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids. Ward, S.E., Loutfy, M.R., Blatt, L.M., Siminovitch, K.A., Chen, J., Hinek, A., Wolff, B., Pham, D.H., Deif, H., LaMere, E.A., Kain, K.C., Farcas, G.A., Ferguson, P., Latchford, M., Levy, G., Fung, L., Dennis, J.W., Lai, E.K., Fish, E.N. Antivir. Ther. (Lond.) (2005)
- Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load. Hestdal, K., Aukrust, P., Müller, F., Lien, E., Bjerkeli, V., Espevik, T., Frøland, S.S. Blood (1997)
- Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. Shresta, S., Sharar, K.L., Prigozhin, D.M., Snider, H.M., Beatty, P.R., Harris, E. J. Immunol. (2005)
- Hepatitis C and progression of HIV disease. Sulkowski, M.S., Moore, R.D., Mehta, S.H., Chaisson, R.E., Thomas, D.L. JAMA (2002)
- Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients. Casado, J.L., Sabido, R., Perez-Elías, M.J., Antela, A., Oliva, J., Dronda, F., Mejía, B., Fortún, J. Antivir. Ther. (Lond.) (1999)
- Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays. Lunel, F., Cresta, P., Vitour, D., Payan, C., Dumont, B., Frangeul, L., Reboul, D., Brault, C., Piette, J.C., Huraux, J.M. Hepatology (1999)
- Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. Urdea, M.S., Wilber, J.C., Yeghiazarian, T., Todd, J.A., Kern, D.G., Fong, S.J., Besemer, D., Hoo, B., Sheridan, P.J., Kokka, R. AIDS (1993)
- Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study. Erb, P., Battegay, M., Zimmerli, W., Rickenbach, M., Egger, M. Arch. Intern. Med. (2000)